View news from other Pharmaceutical sectors:
76-90 of 421 results
XTL Biopharmaceuticals buys Proteologics shares
XTL Biopharmaceuticals has acquired 4,620,356 shares of Proteologics from Teva Pharmaceutical for nearly NIS6.5m($1.6m).
Inward Investment > News
Inward Investment > News
Exemed Pharmaceuticals to buy UCB Indian production facility
India-based Exemed Pharmaceuticals, a manufacturer of active ingredients, is planning to buy UCB's production facility in Vapi, Gujarat, India.
Inward Investment > News
Inward Investment > News
Sigma Life Science unveils CompoZr Transporter Knockout human cell lines in assay-ready format
Sigma-Aldrich's biological products and services business, Sigma Life Science has launched CompoZr Transporter Knockout human cell lines in a consumable, assay-ready plate format.
Inward Investment > News
Inward Investment > News
Pernix to acquire US-based generic and branded pharmaceutical products providers
Pernix Therapeutics has entered into a definitive agreement to acquire Cypress Pharmaceuticals and Hawthorn Pharmaceuticals in Madison, Mississippi, US.
Inward Investment > News
Inward Investment > News
DiscoveRx takes over drug discovery service provider
DiscoveRx in Fremont, US, has purchased BioSeek, a provider of drug discovery services, for an undisclosed sum.
Inward Investment > News
Inward Investment > News
Pioneer Pharma provides additional equity funding to NovaBay
NovaBay Pharmaceuticals has received a $1.5m equity investment from Pioneer Pharma.
Inward Investment > News
Inward Investment > News
Pfizer to take over NextWave Pharmaceuticals
Pfizer is considering buying NextWave Pharmaceuticals, a company that develops a liquid attention deficit hyperactivity disorder drug.
Inward Investment > News
Inward Investment > News
Sygnis to join force with X-Pol for sustainable business model
Sygnis Pharma will join forces with X-Pol Biotech to secure sustainable business model.
Inward Investment > News
Inward Investment > News
Jazz Pharmaceuticals sells women's health business to Meda
Jazz Pharmaceuticals is closing the sale of its women's health business to Meda, a specialty pharmaceutical company, for $95m in cash.
Inward Investment > News
Inward Investment > News
FTC approves Watson's acquisition of Actavis
Watson Pharmaceuticals has received the US Federal Trade Commission (FTC) approval for its acquisition of the Actavis group of companies.
Inward Investment > News
Inward Investment > News
Marlex ships first order to US Department of Defense
Marlex Pharmaceuticals, an acquisition target of ScripsAmerica, has shipped and invoiced the first order of an 8 year pharmaceutical distribution contract with the United States Department of Defense and Defense Logistics Agency (DLA).
Inward Investment > News
Inward Investment > News
EC approves Watson's acquisition of Actavis
US-based global specialty pharmaceutical company, Watson Pharmaceuticals has received European Commission's (EC) approval for its pending acquisition of the privately held Actavis Group.
Inward Investment > News
Inward Investment > News
Takeda to take over LigoCyte Pharmaceuticals
Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60m, with future contingent consideration based on the progress of development projects.
Inward Investment > News
Inward Investment > News
TPG takes over Par Pharmaceutical
TPG and Par Pharmaceutical have announced the completion of Par's purchase by certain TPG affiliates.
Inward Investment > News
Inward Investment > News
Valeant takes over Visudyne from QLT
Valeant Pharmaceuticals has purchased Visudyne, indicated to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration, from QLT.
Inward Investment > News
Inward Investment > News
